Charles Pottier
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 8
- Cancer Cells and Metastasis 4
- Lymphatic System and Diseases 2
-
- Molecular Biology Techniques and Applications 5
- Co-authors
- Rémi Longuespée (9 shared papers)Nor Eddine Sounni (3 shared papers)Margaux Fresnais (2 shared papers)Guy Jérusalem (2 shared papers)Edwin De Pauw (6 shared papers)Gabriel Mazzucchelli (7 shared papers)Philippe Delvenne (6 shared papers)Mark Kriegsmann (4 shared papers)
In The Last Decade
Charles Pottier
15 papers receiving 1.0k citations
Charles Pottier's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 299
- Oncology 362
- Spectroscopy 171
- Molecular Biology 539
- Otorhinolaryngology 34
Countries citing papers authored by Charles Pottier
This map shows the geographic impact of Charles Pottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Pottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Pottier more than expected).
Fields of papers citing papers by Charles Pottier
This network shows the impact of papers produced by Charles Pottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Pottier. The network helps show where Charles Pottier may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Pottier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy Hit paper breakdown → | 2020 | 321 |
| 2 | Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence Hit paper breakdown → | 2021 | 183 |
| 3 | 2020 | 87 | |
| 4 | 2015 | 69 | |
| 5 | 2015 | 63 | |
| 6 | 2016 | 61 | |
| 7 | 2018 | 55 | |
| 8 | 2016 | 43 | |
| 9 | 2014 | 41 | |
| 10 | 2017 | 38 | |
| 11 | 2017 | 28 | |
| 12 | 2017 | 27 | |
| 13 | 2022 | 15 | |
| 14 | 2018 | 14 | |
| 15 | 2025 | 1 |
About Charles Pottier
Charles Pottier is a scholar working on Oncology, Molecular Biology, Immunology, Spectroscopy and Cancer Research, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include Molecular Biology Techniques and Applications (5 papers), Advanced Proteomics Techniques and Applications (4 papers), Cancer Cells and Metastasis (4 papers), Mass Spectrometry Techniques and Applications (4 papers), Cancer Genomics and Diagnostics (3 papers), Lymphatic System and Diseases (2 papers), Immunotherapy and Immune Responses (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Cancer Research (299 citations), Oncology (362 citations), Spectroscopy (171 citations), Molecular Biology (539 citations) and Otorhinolaryngology (34 citations). Charles Pottier has collaborated with scholars based in Belgium, Germany and France. Frequent co-authors include Rémi Longuespée, Nor Eddine Sounni, Margaux Fresnais, Guy Jérusalem, Edwin De Pauw, Gabriel Mazzucchelli, Philippe Delvenne, Mark Kriegsmann, Philippe Delvenne and Michaël Herfs. Their work appears in journals such as PROTEOMICS - CLINICAL APPLICATIONS, Cancers, Oral Oncology, Methods and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.